Drug reference

Ergometrine maleate

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 891, 892

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

Postpartum haemorrhage caused by uterine atony ▶BY INTRAMUSCULAR INJECTION, OR BY SLOW INTRAVENOUS INJECTION ▶Adult: 250–500 micrograms

PDF page 891

Contra Indications

Eclampsia. ﬁrst stage of labour. induction of labour. second stage of labour. sepsis. severe cardiac disease. severe hypertension. vascular disease

PDF page 891

Cautions

Acute porphyrias p. 1120. cardiac disease. hypertension. multiple pregnancy. risk of hypertension associated with intravenous administration

PDF page 891

Safety

Interactions

→Appendix 1: ergometrine

PDF page 891

Side Effects

Abdominal pain. arrhythmias. chest pain. coronary vasospasm. dizziness. dyspnoea. headache. hypertension. myocardial infarction. nausea. palpitations . pulmonary oedema. rash. tinnitus. vasoconstriction. vomiting

PDF page 891

Hepatic Impairment

Manufacturer advises caution in mild to moderate impairment; avoid in severe impairment.

PDF page 892

Renal Impairment

Manufacturer advises caution in mild or moderate impairment. Manufacturer advises avoid in severe impairment.

PDF page 892

Dose and formulations

Medicinal Forms

There can be variation in the licensing of different medicines containing the same drug. Solution for injection ▶Ergometrine maleate (Non-proprietary) Ergometrine maleate 500 microgram per 1 ml Ergometrine 500micrograms/1ml solution for injection ampoules | Genito-urinary system 10 ampoule P £15.00

PDF page 892

Dose text by age group

Adult

250–500 micrograms

First-line fragment. Read the complete Indications and Dose section above.

PDF page 891

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

Ergometrine maleate

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 891, 892

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

Postpartum haemorrhage caused by uterine atony ▶BY INTRAMUSCULAR INJECTION, OR BY SLOW INTRAVENOUS INJECTION ▶Adult: 250–500 micrograms

PDF page 891

Contra Indications

Eclampsia. ﬁrst stage of labour. induction of labour. second stage of labour. sepsis. severe cardiac disease. severe hypertension. vascular disease

PDF page 891

Cautions

Acute porphyrias p. 1120. cardiac disease. hypertension. multiple pregnancy. risk of hypertension associated with intravenous administration

PDF page 891

Safety

Interactions

→Appendix 1: ergometrine

PDF page 891

Side Effects

PDF page 891

Hepatic Impairment

Manufacturer advises caution in mild to moderate impairment; avoid in severe impairment.

PDF page 892

Renal Impairment

Manufacturer advises caution in mild or moderate impairment. Manufacturer advises avoid in severe impairment.

PDF page 892

Dose and formulations

Medicinal Forms

PDF page 892

Dose text by age group

Adult

250–500 micrograms

First-line fragment. Read the complete Indications and Dose section above.

PDF page 891

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.